Sign in
4

Changes in Ownership

Roivant Sciences Ltd. Filed Acc 0001140361-23-046108

CEO disposed of 10,243 shares (other)

  • CEO acquired 17,762 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Gline Matthew · CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-09-27 Exercise or conversion : show line 1 in the form +17,762 1,051,483 D
2023-09-28 Other disposition : show line 2 in the form −10,243 $12.67 $129,779 1,041,240 D

Table II: Derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-09-27 Exercise or conversion : show line 3 in the form Capped Value Appreciation Rights −28,411 $6.40 $181,830 1,164,836 D
2023-09-27 Exercise or conversion : show line 4 in the form Capped Value Appreciation Rights −47,351 $11.50 $544,537 2,225,501 D
Loading xslF345X05/form4.xml…